About Nocion Therapeutics
Nocion Therapeutics is a private company based in Watertown, Massachusetts. It has reported $76,112,511 raised in four offerings on Form D since January 2021. Its chief executive is Richard Batycky.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 2025 | Mar 13, 2026 | $22,999,999fully sold | 13 | $1.7M | EquityRule 506(b) | Form D ↗ |
| Feb 29, 2024 | Mar 13, 2024 | $31,112,518of $70.0M target | 13 | $2.3M | EquityRule 506(b) | Form D ↗ |
| Aug 18, 2021 | Aug 31, 2021amended Aug 24, 2022 | $6,999,997of $16.9M target | 10 | $699K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 5, 2021 | Jan 22, 2021 | $14,999,997of $24.9M target | 11 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $76,112,511 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nocion Therapeutics's Form D filed Mar 13, 2026.
Earlier filings also listed Bernard Silverman (executive officer, last listed Mar 2024), Michael Lipp (executive officer, last listed Aug 2022), Meredith Fisher (director, last listed Aug 2022), Jonathan Garen (executive officer, last listed Aug 2022), Jessica Alston (director, last listed Aug 2022), Christopher Silber (executive officer, last listed Aug 2022) and Bridget Cole (executive officer, last listed Aug 2022).